6618 — JD Health International Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeLarge CapHigh Flyer

Annual income statement for JD Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,383	30,682	46,736	53,530	58,160
Cost of Revenue
Gross Profit	4,917	7,197	9,892	11,865	13,309
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses	18,983	31,903	46,701	52,636	54,914
Operating Profit	399	-1,221	35.6	894	3,246
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-17,072	-901	696	2,693	4,797
Provision for Income Taxes
Net Income After Taxes	-17,235	-1,073	383	2,143	4,157
Minority Interest
Net Income Before Extraordinary Items
Net Income	-17,234	-1,074	380	2,142	4,162
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-17,234	-1,074	380	2,142	4,162
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-7.8	-0.347	0.121	0.677	1.32